GeneDx Holdings Corp. (WGS) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $2.30B, a trailing price-to-earnings ratio of 214.1 and a free-cash-flow yield of 0.7%. Over the most recent reported fiscal year, revenue grew 40.0%.